Where does Clene Nanomedicine, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Clene Nanomedicine, Inc. ranks #45,728 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Clene Nanomedicine, Inc. hold?

Clene Nanomedicine, Inc. holds 5 US utility patents granted between 2018 and 2021, spanning 15 technology areas.

What is Clene Nanomedicine, Inc.'s Innovation Score?

Clene Nanomedicine, Inc. has an Innovation Score of 34.9 out of 100 (49th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Clene Nanomedicine, Inc.'s patent grant rate increasing or decreasing?

Clene Nanomedicine, Inc.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Clene Nanomedicine, Inc.'s patents?

Clene Nanomedicine, Inc.'s patents average 28.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Clene Nanomedicine, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Clene Nanomedicine, Inc.

Q: What technology areas does Clene Nanomedicine, Inc. focus on?

Clene Nanomedicine, Inc.'s top technology area is B22F (Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder) with 4 patents, ranking #291 of 926 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 15 technology areas, recorded in grant years 2018–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B22F (Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Clene ranks #45,728 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 15 technology areas.

#45,728
of 49,997 US assignees by volume: 49th percentile
by Innovation Score (34.9/100): 28.8
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45728 · US Corporation #45,728 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #45,728/49,997
PHOTO-FINISH ClearstoneIP
CPC-FOCUS B22F · 15 areas
INNOV-THIN 34.9/100
CLAIMS-DENSE 28.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: ClearstoneIP, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Clene’s 34.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (18%) Velocity 0.0 pts (0%) Breadth 13.7 pts (39%) Claim depth 15.0 pts (43%)

Qualcomm Incorporated · highest

85
Waddington North… · near

35
Advaced Vision… · near

35
Clene Nanomedicine · this assignee

35
Hochiki · near

35
Maersk Olie OG GAS A/S · near

35
3D Lighting… · lowest

7

What this shows Clene's Innovation Score is 34.9/100 (49th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Clene?

Each dot is one of Clene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Clene’s own 28.8 claims/patent is ABOVE the 17.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Clene vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Clene's grants concentrate

Clene Nanomedicine, Inc. is a focused PatentsView assignee: 15 CPC subclasses with 80% of grants classified under B22F (Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder). Peak complete grant year is 2018 (2 grants) versus a trough of 1 in 2021. By volume, Clene sits between ClearstoneIP, Inc. and Clipchamp IP Pty Ltd.

Clearstoneip

5
Clearview AI

5
Cleer Gear

5
Clementia Pharmac…

5
Clicked

5
Clinical Micro Se…

5
Clinical Referenc…

5
Clipchamp IP Pty

5
Clene Nanomedicine ◀

5

What this shows Clene holds 5 patents at rank #45,870, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Clene

By rank, the assignees closest to #45,870 in granted patent volume.

Leaders in B22F (Working Metallic Powder)

Other assignees with the most granted patents in Clene's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Clene, neither rank-band nor same-CPC leaders (those blocks stay above). In B22F (Working Metallic Powder), Clene ranks #291 of 926 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (35 here).

Advaced Vision Technology (A.V.T.) Ltd. 35 Maersk Olie OG GAS A/S 35 Hochiki Corporation 35 Waddington North America, Inc. 35

Clene's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 49th percentile higher than 49% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

Clene Nanomedicine, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	2	40.0%
2019	2	40.0%
2021	1	20.0%

Which technologies does Clene Nanomedicine, Inc. patent most?

B22F - Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 3

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 3

B01J - Chemical OR Physical Processes, e.g. Catalysis OR Colloid CHEMISTRY; Their Relevant Apparatus 3

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

C30B - Single-crystal Growth ; Unidirectional Solidification OF Eutectic Material OR Unidirectional Demixing OF Eutectoid MATERIAL; Refining BY Zone-melting OF Material ; Production OF A Homogeneous Polycrystalline Material With Defined Structure ; Single Crystals OR Homogeneous Polycrystalline Material WI 2

Y02A - Technologies FOR Adaptation TO Climate Change 2

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 1

C25C - Processes FOR THE Electrolytic Production, Recovery OR Refining OF METALS; Apparatus Therefor 1

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 1

C25B - Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor 1

H05H - Plasma Technique ; Production OF Accelerated Electrically-charged Particles OR OF NEUTRONS; Production OR Acceleration OF Neutral Molecular OR Atomic Beams 1

C22B - Production AND Refining OF Metals ; Pretreatment OF RAW Materials 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Clene Nanomedicine, Inc.'s patent record in context - here's where to go next.

Clene Nanomedicine, Inc.'s lead technology class is B22F (Working Metallic POWDER; Manufacture OF Articles From Metallic POWDER; Making Metallic Powder ; Apparatus OR Devices Specially Adapted FOR Metallic Powder), 80% of its portfolio - see every assignee active in that class. Explore B22F
Ranked #45,728 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Clene Nanomedicine, Inc. against ClearstoneIP, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 34.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.